Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Marty Makary
Biotech
82% of industry CEOs concerned about FDA's abilities: survey
Biotech CEOs worry that added volatility in an already high-risk industry will discourage investment or will drive it to other countries.
Gabrielle Masson
Nov 21, 2025 4:38pm
FDA unveils hiring spree, new comms program to speed reviews
Nov 21, 2025 11:43am
FDA unveils new pathway to speed custom gene editing therapies
Nov 12, 2025 5:00pm
Regeneron, Sanofi receive 1- to 2-month priority review vouchers
Oct 17, 2025 8:30am
Fierce Pharma
Under Trump, FDA seeks to abandon expert reviews of new drugs
Sep 12, 2025 9:50am
FDA rejects another ultrarare disease prospect
Sep 8, 2025 10:59am